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Abstract 
     A current Japanese standard for drug efficacy classification is comprised of words from both pharmaceutical and external 
fields. A previously reported method was based on clustering of descriptions in medical package inserts for circulatory drugs. In 
this report, a new criteria is proposed to extract clusters at each junction of a dendrogram relative to the number of drugs and the 
nouns in the drug description. Results of a comparative analysis indicate that the proposed method provides more detailed 
classification than the previous method. 
© 2014 The Authors. Published by Elsevier Ltd. 
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1. Introduction 
In Japan, a variety of drug efficacies are classified by therapeutic category and designated with a three-digit 
number. This number is based on the Japan Standard Commodity Classification [1]. In recent years, doctors have 
utilized a computerized drug ordering system. The development of a crosschecking method for drug ordering is 
important to prevent incorrect prescription input. We expect that drug classification based on efficacy can be 
crosschecked with the drug order because the efficacy information tightly connects with disease conditions. 
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However, the classification includes non-efficacy viewpoints; therefore, the crosscheck might function 
inappropriately.  
The World Health Organization [2] recommends the Anatomical Therapeutic Chemical Classification System, 
which is a classification method for drugs based on the consumption statistics. However, it is classified from both 
efficacy and non-efficacy viewpoints [3]. Therefore, this classification system is irrelevant for crosschecking 
purposes. 
Ishida et al. [4] proposed a new classification method based on nouns that appear in the description of medical 
package inserts of circulatory drugs (over 1,300 documents). They reported that the method is useful for circulatory 
drugs; however, they did not clarify whether the method is useful for all medical drugs. Additionally, it is not clear 
how to determine a threshold value in their method (see below for details). Our aim is to improve their classification 
method based exclusively on drug efficacy and to develop a method that is applicable to all ethical drugs (over 
10,000 documents). The remainder of this paper is organized as follows: First, Section 2 describes how we treated 
target data in this study. Section 3 reviews the method of classification and results presented by Ishida et al. [4]. 
Section 4 describes our method and results obtained by applying the proposed method application to all ethical drugs. 
In Section 5, we evaluate our method, and in Section 6, we present our conclusions and suggestions for future work. 
2. Target data 
We analyzed 9,358 efficacy documents from 10,054 medical package inserts registered in Standard Generalized 
Markup Language (SGML) format by the Pharmaceuticals and Medical Devices Agency, Japan [5]. Nabeta et al. 
[6,7,8,9,10] proposed a method to extract data from medical package inserts in SGML format, and we have 
extracted data from efficacy documents using the same method. Each efficacy document is described in Japanese. In 
this paper, we have translated Japanese text to English to facilitate easy comprehension. 
3. Classification by the previous study 
3.1. Noun vector 
The efficacy documents frequently include specific nouns, such as names of diseases and symptoms; therefore, 
Ishida et al. [4] extracted nouns by means of morphological analysis [11]. 
They utilized a noun vector to obtain a set of concepts contained in the efficacy document for each drug. The 
noun vector has a value of 1 for an element if the corresponding word appears in the document and has a value of 0 
if it does not appear. Table 1 shows an example of the noun vectors for the specific efficacy phrase, “頭部外傷に伴
う意識障害” (consciousness disturbance induced by external head injury). As the nouns in the third and fifth 
columns do not appear in that phrase, values of 0 are assigned to them. Ishida et al. [4] obtained a dendrogram based 
on the distance between the noun vectors given by Euclidean distance and the cluster distance measured by the 
Ward method [12,13].  
Table 1. Example of the noun vectors. 
Noun 頭部(head) 外傷(external injury) 先天(inborn) 意識(consciousness) 手術(operation) 障害(disturbance) ・・・ 
Value 1 1 0 1 0 1 ・・・ 
3.2. Division index 
Ishida et al. [4] proposed a division index to determine which cluster is extracted from the dendrogram. The 
division index of a cluster, 𝐼௖ = 𝑁௖ ቀ𝐸௕௘௙௢௥௘ − 𝐸௔௙௧௘௥(𝑐)ቁ, is calculated at each junction of the dendrogram and 
exhibits the increase of noun cohesion in efficacy among drugs caused by the cluster division. The number 𝑁௖ 
counts how many nouns are in the cluster 𝑐 after division. The vale 𝐸௕௘௙௢௥௘  is the entropy of the cluster before 
division (i.e., the degree of word assembly in the cluster), and 𝐸௔௙௧௘௥(𝑐) is the entropy of the cluster 𝑐 after division. 
The entropy 𝐸 is given as follows:  
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𝐸 = −∑ 𝑞௪ே௪ୀଵ {𝑃௪௖ 𝑙𝑜𝑔 𝑃௪௖ + (1 − 𝑃௪௖) 𝑙𝑜𝑔(1 − 𝑃௪௖)}, (1) 
   𝑃௪௖ = ே
೎ೢ
ே೎         𝑞௪ =
௡ೢ
௡ೌ೗೗
 , 
where 𝑁௪௖  is the number of drugs in the cluster 𝑐 including noun 𝑤 in the efficacy documents, 𝑛௔௟௟ is the total 
number of nouns appearing in the efficacy documents in the cluster before division, and 𝑛௪ is the total number of 
noun 𝑤 in the efficacy documents. If the value of [𝐸௕௘௙௢௥௘ − 𝐸௔௙௧௘௥(𝑐)] is a large value, the division decreases the 
variation of words in the cluster. 
 They gave a condition to extract the clusters with 𝐼௖ greater than threshold α: 
𝐼௖ = 𝑁௖ ቀ𝐸௕௘௙௢௥௘ − 𝐸௔௙௧௘௥(𝑐)ቁ > 𝛼.  (2) 
They applied the abovementioned equations to the clustering of circulatory drugs. Figure 1(a) plots Iୡ for the 
drugs. In the figure, the blue dots represent the cluster of the larger number of drugs after division, and the red dots 
are smaller clusters of drugs after division. The division index 𝐼௖ of each cluster is on the vertical axis, and the 
horizontal axis shows the ratio 𝑀 of the number of drugs in the cluster before division to the total number of drugs. 
We can see that large 𝐼௖ values in Fig. 2(a) appear in both the higher and lower ratio regions of the drugs. The 
latter case includes clusters that are not extracted even though 𝐼௖ is greater than α. There were no obvious criteria to 
exclude these clusters from the extraction and determine the value of α. 
4. Improvement of the classification method 
4.1. The relationship between the number of drugs and words 
Figure 2 shows the dendrogram of the clustering method applied to efficacy documents of all ethical drugs in 
Japan. 
Naive application of Eq. (2) to the dendrogram in Fig. 2 gives Fig. 1(b), which shows a relationship between 𝐼௖ 
and the ratio 𝑀 of the number of drugs similar to that shown in Fig. 1(a). To investigate the results in detail, we also 
plotted the distribution of ൫Eୠୣ୤୭୰ୣ − Eୟ୤୲ୣ୰(c)൯ and the distribution of Nୡ on the drug number ratio 𝑀 (Fig. 3, Fig. 4). 
Figure 3 shows that (Eୠୣ୤୭୰ୣ − Eୟ୤୲ୣ୰(c)) tends to be large for a small cluster c. This result is easy to understand 
because a small cluster has a small number of words with small variation. 
In Fig. 4, we can observe large Nୡ at the lower 𝑀 region. It should be noted that Nୡ is introduced in 𝐼௖ to reduce 
the small size effect of clusters on (Eୠୣ୤୭୰ୣ − Eୟ୤୲ୣ୰(c)). Ishida et al. [4] expected that Nୡ would be small for a small 
cluster c, and multiplied it by the entropy difference to overcome this difficulty. Their assumption is right for the 
relatively higher 𝑀 region. However, Fig. 3 suggests that their assumption is wrong in the lower 𝑀 region. This 
suggests that there is a new mechanism that affects the lower region. 
To investigate change in the number of words against the ratio of the number of drugs in detail, we transformed 
Fig. 4 into a bi-logarithmic form. Figure 5 shows the relationship of the number of drugs and words in bi-
logarithmic form. The horizontal axis represents log𝑀, where 𝑀 is the ratio of the number of drugs in the cluster 
before division to the total number of drugs. The vertical axis represents log𝑁௖ where 𝑁௖ is the same as in Eq. (2).  
In Fig. 5, we can see that there are two parts in this graph, the downward slope from the point of log𝑀 = 0 and 
the region with crowded dots. The right part of the slope and the crowded dots form straight lines. This indicates that 
𝑁௖ and 𝑀 satisfy the relationship: 
𝑙𝑜𝑔 𝑁௖ = 𝜌 𝑙𝑜𝑔𝑀 + 𝑙𝑜𝑔𝐷,  (3) 
where ρ and D are constants. This leads to the power law equation, Nୡ = DM஡. The right part of the slope and the 
crowded dots have approximately the same ρ value.  
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Fig. 1.(a) Division index of each cluster for circulatory drugs; (b) Division index of each cluster for all of medical drugs. 
 
 
Fig. 2. Dendrogram applied to efficacy documents of all ethical drugs in Japan. 
 
Fig. 3. The relationship of the ratio of the number of drugs and the entropy difference. 
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Fig. 4. The relationship of the ratio of the number of drugs and the number of words. 
 
Fig. 5. The bi-logarithmic graph transformed from Fig.4. 
 
Fig. 6. Schematic dendrogram representing the corresponding relationship between clusters in the dendrogram and lines in Fig.5. 
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Figure 6 illustrates how the clusters in the dendrogram are divided. At each junction, a cluster is divided into two 
sub-clusters denoted by a blue circle and a red square. The blue circle indicates a larger sub-cluster, and the red 
square indicates a smaller sub-cluster. We confirmed that the sequence of sub-clusters marked with blue circles 
(surrounded by a green dotted line) corresponds to the downward slope in Fig. 5. Each branch of sub-clusters 
marked with blue circles starting from a sub-cluster with red square circles (surrounded by red dotted lines) 
corresponds to a line of crowded dots. 
These facts suggest that Nୡ has a fractal feature, i.e., cluster division corresponding to the slope and the lines of 
crowded dots share the same mechanism to decompose clusters independently from the size of clusters. 
4.2. Extraction of the clusters 
The above consideration suggests that smaller sub-clusters derived from larger clusters on the slope give us the 
sets of drugs whose efficacies are similar because such smaller sub-clusters have small variation of words and 
should be coherent in terms of efficacy descriptions. Moreover, further divisions of such sub-clusters can result in 
fragments with the same efficacies. The junctions corresponding to the right part of the red line in Fig. 5 give the 
required sub-clusters. With reference to Eq. 2, this condition is equivalent to α = 7.       
The threshold α = 7 provides 26 clusters for all ethical drugs in Japan, as shown in Table 2. The primary 
efficacies in Clusters 1 to 26 do not overlap significantly. Cluster 26, which represents 7% of the total number of 
drugs, is comprised of miscellaneous efficacies. We should also note that 60% of all drugs were classified into the 
26 clusters. The remaining 40% are insufficiently classified to be denoted as “a mixed cluster” (not indicated in 
Table 2). 
Table 2. Efficacies of drugs included in each cluster for all medical drugs. 
Cluster No. Main efficacy Cluster No. Main efficacy 
1 nutrient supplement 14 cold medicine 
2 analgesic, antiphlogistic 15 allergic, vasomotor nerve 
3 eczema, dermatitis 16 depression 
4 bronchitis, asthma 17 anesthetic 
5 antiseptic, dermatomycosis 18 abnormal digestion 
6 anorexia, nausea 19 cataract 
7 hypertension 20 insomnia, mental instability 
8 herpes simplex, metabolic 
disorder of Vitamin D 
21 pain 
9 epilepsia, diabetes 22 solvents 
10 prescription 23 ulcerative 
11 constipation 24 schizophrenia 
12 respiratory, dermatomicosys 25 glaucoma, ocular hypertension 
13 suppurative, ophthalmic 26 miscellaneous 
5. Evaluation 
To evaluate the improvement of the proposed method, we applied it to the data from the efficacy documents for 
circulatory drugs used in the previous study [4].  
The results presented in Table 3 were obtained under the condition that the threshold α = 42. Using the proposed 
method, we obtained 22 clusters; contrastingly, in the previous study, only 13 clusters were obtained. In Table 3, the 
clusters in the red column (Clusters 1 to 11) were extracted using both methods.  
One cluster extracted using the previous method was further divided into four clusters by our proposed method: 
Clusters 17 and 20 to 22 (blue). These four clusters included the word “hypertension.” Consequently, the previous 
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result put them in one cluster because it treated “hypertension” in a broad sense. The proposed method shed light on 
pharmaceutically different efficacies in a narrower sense: “hypertension and pulmonary arterial hypertension” in 
Cluster 21, “hypertension and angina” in Cluster 22, and so on. 
A mixed cluster in the previous results was divided into seven different clusters: Clusters 12−16 and Clusters 
18−19 (green). Each cluster has a specific description in addition to the common word “hypertension”: “bronchial 
asthma” in Cluster 14, “congestive heart failure” in Cluster 16, and so on. This suggests that the proposed method 
generates more detailed clusters than the previous method. 
 
Table 3. Efficacies of drugs included in each cluster for circulatory drugs. 
Cluster No. Main efficacy Cluster No. Main efficacy 
1 disturbance of consciousness through head injury 12 thrombus, embolus, nephrosis 
2 hypertension, chronic cardiac failure 13 tachyarrhythmia, arteriosclerosis obliterans 
3 chronic arterial obstruction, ductus arteriosus 14 bronchial asthma, bronchitis 
4 acute circulatory failure, uremic 15 hypertensive emergency 
5 hypertension, renal edema 16 congestive cardiac failure 
6 intracranial hypertension, brain infarction and hemorrhage 17 essential hypertension, renal hypertension 
7 tachyarrhythmia 18 cerebral vasospasm, bronchial asthma 
8 hyperlipemia 19 cerebral infarction sequelae 
9 essential hypertension 20 essential hypertension 
10 congestive and congenital cardiac failure 21 hypertension, pulmonary arterial hypertension 
11 hypertension, angina, renal parenchymal hypertension 22 hypertension, angina 
6. Conclusion 
First, we improved a previous method based on the nouns that appear in the indications and efficacy statements in 
medical package inserts. The target data was comprised of 9,358 efficacy documents from 10,054 medical package 
inserts. The previous work by Ishida et al. [4] focused only on circulatory drugs; comparatively, our target was all 
ethical drugs in Japan. We extracted the nouns by morphological analysis and applied noun vectors that were used to 
generate a dendrogram.  
Next, we examined the division index used to extract groups of drugs with the similar efficacies. As in the 
previous study, naive application of the division index to the dendrogram was problematic. To investigate the results 
in detail, we observed the distribution of ൫Eୠୣ୤୭୰ୣ − Eୟ୤୲ୣ୰(c)൯ and the distribution of Nୡ on the drug number ratio 𝑀 
and found that large Nୡ values are obtained at the lower 𝑀 region. We also found that there are two components in 
the relationship between log Nୡ and log𝑀, the downward slope from the point of log𝑀 = 0 and the region with 
crowded dots. The right part of the slope and the crowded dots form straight lines, which indicates that 𝑁௖ and 𝑀 
satisfy the power law, Nୡ = DM஡ . This, in turn, suggests that Nୡ  has a fractal feature, and cluster division 
corresponding to the slope and the lines of crowded dots share the same mechanism to decompose clusters 
independent of cluster size. Based on this consideration, we proposed a standard to determine the threshold value in 
the division index. As a result, we extracted 26 clusters for all ethical drugs. 
Finally, we evaluated the extent to which the proposed method has been improved by using data for circulatory 
drugs and comparing the results to those of the previous study. The previous method extracted 13 clusters; our 
improved method was able to extract 22 clusters. By comparing the content of each cluster, we determined that the 
proposed method provided more finely divided clusters than the previous method. Accordingly, the effectiveness of 
the dividing criteria used in this study was shown. In the proposed drug classification method, the introduction of 
classification criteria provides more precise clustering.  
However, the proposed method can be improved further. In our results, particular clusters contained drugs with a 
variety of efficacies. In future, we will propose a method to provide classification with greater precision. 
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